Dr.
Vazyme, a global supplier specializing in design, manufacture and application of bioactive compounds, is committed to expanding the application fields of core technologies in life science, in vitro diagnostics, bio-medicine, and others. Leveraging its expertise in bioactive compounds, Vazyme is developing innovative biosolutions to bolster the research and development in life science.
Headquartered in the
"We are very pleased to achieve this global strategic cooperation, as partners with a solid foundation for cooperation - Vazyme had established deep collaboration with
Vazyme: accelerating global roadmap with controllable upstream technology development and end product manufacturing capabilities
Vazyme reported strong financial performance in 2022. The company's operating revenue reached
Vazyme's strong financial performance in 2022 can be attributed to its focus on innovation and investment in cutting-edge technologies. To meet the varying needs of customers and partners, Vazyme invested a total of
Vazyme thrives to deliver comprehensive solutions tailored to the diverse needs of the customers leveraging its core technologies, and aims to steadfastly enhance public health together with its partners towards a healthier, safer, and greener future.
Looking forward, Vazyme and Azenta will carry out global cooperation in the fields of automated sample solutions, oligo synthesis, molecular biology services, and GLP standard specification services, fully integrating the resources and advantages of both companies to lead innovative breakthroughs, jointly developing international markets, and contributing to the life and health of all people.
About Vazyme
Established in 2012, Vazyme (688105.SH) is a global enzyme-based biosolution supplier with more than 200 types of genetically engineered recombinant enzymes, over 1,000 types of high-performance materials and over 1,000 end products. It was public listed on the
With a mission to create value for customers by pursuing the highest standards in product and service quality, the company is now serving customers in more than 60 countries and regions worldwide.
View original content to download multimedia:https://www.prnewswire.com/news-releases/vazyme-signs-global-strategic-cooperation-agreement-with-azenta-301838715.html
SOURCE Vazyme
© Canada Newswire, source